Neurocure Uses qEEG and Neurotherapy to Successfully Treat Clinical Depression

Depression is a major mental disorder. It affects millions of people across the globe. Cases vary from mild to the most severe, clinical depression. Clinical depression, also known as depressive disorder, affects millions of adults in the U.S. alone. According to the National Institute of Mental Health that number was over 10 million in 2016. The main problem with clinical depression is that its exact cause is unknown. Science has discovered contributing factors like genetics, brain chemistry, and hormones but no real proof positive cause. This is why treatment centers like Neurocore focus specifically on depression in their ongoing care. Using the latest innovations in neuroscience Neurocore treatment centers apply cutting edge tech to decades old problems. Some of the latest treatments have proven beneficial for clinical depression, but a concrete cure remains unfound.

The traditional treatment for clinical depression is either antidepressants, psychotherapy, or a marriage of the two. This can be effectual as a deterrent but not a cure. Also, antidepressants carry their own series of drawbacks. EEG has created a better way to detect depression by analyzing the mind’s electrical impulses. This has led to a better awareness of the disorder. Neurotherapy is the latest treatment to be used for depression. Doctors and researchers alike have been applying it for decades.

Neurotherapy utilizes the detection capability of EEG to track the brains activity. This helps practitioners discover the causes of depression and assist patients in training the brains to resist depression. This type of treatment is at the heart of Neurocore’s medication-free depression treatment program. Using neurofeedback bolstered by innovations like qEEG brainwave mapping technology, comprehensive brain training sessions can be used to tackle the toughest forms of depression. This program is designed to free suffers of any type of depression from the use of medication, while utilizing cutting edge tech to find solutions. Neurocore’s program, which lasts 30-sessions, has been successful so far. 84% of patients claimed to have experienced a reduction in their depression systems. 51% were completely cured of the effects. This new study is at the forefront of clinical depression treatment.